Statistics for Nykode Therapeutics AS (id:10313 NYKD)
Valuation metrics
Market cap
950.25M
Enterprise value
8.77B
Trailing P/E (ttm)
-25.00
Forward P/E
-18.19
PEG ratio
-18.19
Price/Sales (ttm)
145.83
Price/Book (mrq)
5.55
Enterprise Value/Revenue
121.60
Enterprise Value/EBITDA
-13.63
Overview
Shares outstanding
326.55M
Float
192.89M
Shares short
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
2.67M
Average volume (90 days)
Price summary
52-Week low
1.55
52-Week high
21.40
52-Week change
-574.67%
Beta
1.31
50-Day moving average
4.04
200-Day moving average
10.75
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
0.00%
Operating margin
-2,018.32%
Operational effectiveness
Return on assets
-19.95%
Return on equity
-25.99%
Income statement
Revenue (ttm)
5.00
Revenue per share (ttm)
5.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-643,373,770.00
Net income to common (ttm)
-419,557,911.00
Diluted EPS (ttm)
-1.33
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
1.51B
Total cash per share (mrq)
3.00
Total debt (mrq)
52.96M
Total Debt/Equity (mrq)
3.15
Current ratio (mrq)
928.00%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-966,781,380.00
Levered free cash flow (LFCF)
-457,175,928.00